Molecular deletion patterns in Duchenne and Becker type muscular dystrophy

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Duchenne (DMD) and Becker (BMD) muscular dystrophies are X-linked myopathies caused by mutations in the dystrophin gene.
• Accurate genetic diagnosis is crucial for patient management, carrier screening, and prenatal testing.

Purpose of the Study:

• To analyze DNA from DMD and BMD patients to identify deletion patterns.
• To correlate deletion locations with disease phenotype.
• To assess the utility of specific probes for diagnosis and carrier screening.

Main Methods:

• DNA analysis using 12 genomic and cDNA probes in 80 DMD and 15 BMD patients.
• Detection and confirmation of deletions using Southern blot hybridization.
• Mapping of deletion breakpoints within the dystrophin gene.

Main Results:

• Genomic probes detected deletions in 30% of DMD and 67% of BMD patients.
• cDNA probes confirmed these and identified additional deletions, totaling 66% of patients with detectable deletions.
• The majority of deletions were localized between cDNA kilobases 6.7-9.7 and 0.5-3.5.
• Three specific cDNA probes (1-2a, 7, and 8) detected 90% of all deletions.
• Deletion patterns differed between DMD and BMD, aligning with the reading frame theory.

Conclusions:

• A significant proportion of DMD and BMD cases are associated with dystrophin gene deletions.
• Specific cDNA probes are highly effective for detecting these deletions, facilitating carrier detection and prenatal diagnosis.
• Deletion breakpoint location and the number of deleted exons correlate with DMD or BMD phenotype, supporting the reading frame theory.